EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

DPP Inhibition Enhances the Efficacy of PD-1 Blockade by Remodeling the Tumor Microenvironment in Lewis Lung Carcinoma Model

Mengrong Lei, Junyan Liu, Ying Gao, Wenting Dai iD, Hanxue Huang, Qingqing Jiang, Zhaoqian Liu iD

Biomolecules · 2024

DOI: 10.3390/biom14040391 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2024. Verfasst von Mengrong Lei und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, and National Clinical Research Center for Geriatric Disorders, Xiangya…. Hauptthemen laut MEDLINE: Carcinoma, Lewis Lung, Programmed Cell Death 1 Receptor, Tumor Microenvironment. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Project Program of the National Clinical Research Center for Geriatric Disorders, Science and Technology Program of Changsha.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The remarkable efficacy of cancer immunotherapy has been established in several tumor types. Of the various immunotherapies, PD-1/PD-L1 inhibitors are most extensively used in the treatment of many cancers in clinics. These inhibitors restore the suppressed antitumor immune response and inhibit tumor progression by blocking the PD-1/PD-L1 signaling. However, the low response rate is a major limitation in the clinical application of PD-1/PD-L1 inhibitors. Therefore, combination strategies that enhance the response rate are the need of the hour. In this investigation, PT-100 (also referred to as Talabostat, Val-boroPro, and BXCL701), an orally administered and nonselective dipeptidyl peptidase inhibitor, not only augmented the effectiveness of anti-PD-1 therapy but also significantly improved T immune cell infiltration and reversed the immunosuppressive tumor microenvironment. The combination of PT-100 and anti-PD-1 antibody increased the number of CD4+ and CD8+ T cells. Moreover, the mRNA expression of T cell-associated molecules was elevated in the tumor microenvironment. The results further suggested that PT-100 dramatically reduced the ratio of tumor-associated macrophages. These findings provide a promising combination strategy for immunotherapy in lung cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Lewis LungProgrammed Cell Death 1 ReceptorTumor MicroenvironmentAnimalsMiceCD8-Positive T-LymphocytesCell Line, TumorDipeptidyl Peptidase 4Dipeptidyl-Peptidase IV InhibitorsImmune Checkpoint InhibitorsImmunotherapyMice, Inbred C57BL

Stichwörter der Autor:innen

Lewis lung carcinomaPT-100anti-PD-1combination immunotherapytumor microenvironment

Substanzen

Dipeptidyl Peptidase 4Dipeptidyl-Peptidase IV InhibitorsImmune Checkpoint InhibitorsPdcd1 protein, mouseProgrammed Cell Death 1 Receptor

Autor:innen und Institutionen

  • Department of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, and National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha 410008, China.
  • Institute of Clinical Pharmacology, Engineering Research Center for Applied Technology of Pharmacogenomics of Ministry of Education, Central South University, Changsha 410078, China.
  • Department of Orthopaedics, Xiangya Hospital, Central South University, Changsha 410008, China.
  • Department of Pharmacy, Xiangya Hospital, Central South University, Changsha 410008, China.
  • Key Laboratory of Biological Nanotechnology of National Health Commission, Xiangya Hospital, Central South University, Changsha 410008, China.

ORCID-Profile: Wenting Dai, Zhaoqian Liu

Förderung

  • National Natural Science Foundation of China
  • Project Program of the National Clinical Research Center for Geriatric Disorders
  • Science and Technology Program of Changsha

Zitieren

APA

Lei, M., Liu, J., Gao, Y., Dai, W., Huang, H., Jiang, Q., & Liu, Z. (2024). DPP Inhibition Enhances the Efficacy of PD-1 Blockade by Remodeling the Tumor Microenvironment in Lewis Lung Carcinoma Model. Biomolecules. https://doi.org/10.3390/biom14040391

Vancouver

Lei M, Liu J, Gao Y, Dai W, Huang H, Jiang Q, et al. DPP Inhibition Enhances the Efficacy of PD-1 Blockade by Remodeling the Tumor Microenvironment in Lewis Lung Carcinoma Model. Biomolecules. 2024. doi:10.3390/biom14040391

BibTeX
@article{Lei2024,
  author = {Lei, Mengrong and Liu, Junyan and Gao, Ying and Dai, Wenting and Huang, Hanxue and Jiang, Qingqing and Liu, Zhaoqian},
  title = {DPP Inhibition Enhances the Efficacy of PD-1 Blockade by Remodeling the Tumor Microenvironment in Lewis Lung Carcinoma Model},
  journal = {Biomolecules},
  year = {2024},
  doi = {10.3390/biom14040391}
}
Kostenlos starten →